Imm Cancer Research Results
Imm, immunostimulatory: Click to Expand ⟱
| Source: |
| Type: |
Enhance the immune response in patients.
|
CRC, Colorectal Cancer: Click to Expand ⟱
Colorectal cancer is a broader term that encompasses both colon and rectal cancer.
|
Scientific Papers found: Click to Expand⟱
*Inflam↓, *antiOx↑, AntiCan↑, BioAv↑, Apoptosis↑, angioG↓, Imm↝, ChemoSen↑, chemoP↑,
GutMicro↑, IBI↑, TumCG↓, Inflam↓, Imm↝, eff↑,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCG↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1,
Barriers & Transport(tgid=15) ⓘ
IBI↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Imm↝, 2, Inflam↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, ChemoSen↑, 1, eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, chemoP↑, 1,
Total Targets: 12
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Total Targets: 2
Scientific Paper Hit Count for: Imm, immunostimulatory
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:6 Cells:% prod#:% Target#:1332 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page